Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Tumor Microenvironment 33%
• Tumor Growth 33%
• G Protein Coupled Receptor 33%
• Clinical Trial 33%
• Receptor Antagonist 16%
• Anti-Inflammatory Drug 16%
• Inflammatory Disease 16%
• Metastasis 16%
• Interleukin 8 16%
• Enalapril Maleate 16%
• Survival 16%
• Chronic Inflammation 16%
• Small Interfering RNA 16%

Biochemistry, Genetics and Molecular Biology

• Tumor Progression 33%
• Small Molecule 16%
• Signal Transduction 16%
• Interleukin 8 16%
• Cell Survival 16%
• Angiogenesis 16%
• Small Interfering RNA 16%
• Neutralizing Antibody 16%
• Development 16%
• Receptor Antagonist 16%

Immunology and Microbiology

• Angiogenesis 16%
• Development 16%
• Inflammation 16%
• Neutralizing Antibody 16%
• Signal Transduction 16%
• Inflammatory Disorder 16%
• Cell Survival 16%
• Interleukin 8 16%